2019, Number 2
Jaw secondary osteonecrosis to bisphosphonates. Case report
Language: Spanish
References: 11
Page: 111-120
PDF size: 324.51 Kb.
ABSTRACT
Background: Osteonecrosis of the jaws, secondary to the administration of bisphosphonates is a pathology that has been increasing from the use of this drug, either orally or intravenously.Objective: To offer clinical-surgical education and raise awareness among health professionals concerning jaw osteonecrosis to bisphosphonate.
Case report: A 74-year-old patient with jaw secondary Osteonecrosis to bisphosphonates, located in the right mandibular body was reported; and intraoral segmental mandibulectomy performed.
Conclusions: Osteonecrosis of the jaws associated with the use of bisphosphonates is a complication that affects the life quality of these patients. The patient in this case, one month after the treatment, was well clinically and with good results in the imaging tests.
REFERENCES
Sartori P, Rajcovich G, Taborda N, Saleme Daza MC, Nally C. Osteonecrosis del maxilar inferior por bifosfonatos. Presentación de caso. Rev. argent. radiol. [Internet]. 2015 [citado 2018 ene 21];79(1):40-6. Disponible en: https://www.elsevier.es/es-revista-revista-argentina-radiologia-383-pdf-S0048761914001148
Goytia RN, Salama A, Khanuja HS. Bisphosphonates and Osteonecrosis: Potential Treatment or Serious Complication. Orthop Clin North Am [Internet]. 2009 [cited 2018 ene 21];40(2):223-34. Available from: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0030589808001016.pdf?locale=es_ES&searchIndex=
Cardona F, Bagán JV, Sáinz E, Figuerido J, Giner F, Vidán FJ. Osteonecrosis de los maxilares por bisfosfonatos: Actualización y puesta al día. Anales Sis San Navarra [Internet]. 2009 [citado 2018 dic 19];2(3):423-37. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1137-66272009000500012
Silverman SL, Landesberg R. Osteonecrosis of the jaw and the role of bisphosphonates: a critical review. Am J Med [Internet]. 2009 [cited 2018 Jan 19];122(2 Suppl):S33-45. Available from: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0002934308011935.pdf?locale=es_ES&searchIndex=
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Bhoomi M, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillo Fac Surg [Internet] 2014 [cited 2018 Jan 19];72(10):1938-56. Available from: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0278239114004637.pdf?locale=es_ES&searchIndex=
Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, et al. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab [Internet]. 2010 [cited 2018 Jan 19];28(4):365-83. Available from: https://link.springer.com/article/10.1007%2Fs00774-010-0162-7
Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth Extraction in Patients Taking Intravenous Bisphosphonates: A Preventive Protocol and Case Series. J Oral Maxillofac Surg [Internet]. 2010 [cited 2018 Jan 19];68(1):107-10. Available from: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0278239109014827.pdf?locale=es_ES&searchIndex=